"Infusions, Parenteral" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The administration of liquid medication, nutrient, or other fluid through some other route than the alimentary canal, usually over minutes or hours, either by gravity flow or often by infusion pumping.
| Descriptor ID |
D007263
|
| MeSH Number(s) |
E02.319.267.510
|
| Concept/Terms |
Intra-Abdominal Infusions- Intra-Abdominal Infusions
- Infusion, Intra-Abdominal
- Infusions, Intra-Abdominal
- Intra Abdominal Infusions
- Intra-Abdominal Infusion
- Peritoneal Infusions
- Infusion, Peritoneal
- Infusions, Peritoneal
- Peritoneal Infusion
- Intraperitoneal Infusions
- Infusion, Intraperitoneal
- Infusions, Intraperitoneal
- Intraperitoneal Infusion
|
Below are MeSH descriptors whose meaning is more general than "Infusions, Parenteral".
Below are MeSH descriptors whose meaning is more specific than "Infusions, Parenteral".
This graph shows the total number of publications written about "Infusions, Parenteral" by people in this website by year, and whether "Infusions, Parenteral" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 0 | 2 | 2 |
| 2007 | 0 | 3 | 3 |
| 2008 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Infusions, Parenteral" by people in Profiles.
-
Larbre V, Alyami M, Mercier F, Vantard N, Bonnefoy I, Opsomer MA, Villeneuve L, Bakrin N, Rioufol C, Glehen O, Kepenekian V. No Renal Toxicity After Repeated Treatment with Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Patients with Unresectable Peritoneal Metastasis. Anticancer Res. 2018 Dec; 38(12):6869-6875.
-
Date AA, Nagarsenker MS. Design and evaluation of microemulsions for improved parenteral delivery of propofol. AAPS PharmSciTech. 2008; 9(1):138-45.
-
Date AA, Nagarsenker MS. Parenteral microemulsions: an overview. Int J Pharm. 2008 May 01; 355(1-2):19-30.
-
Buchowski MS, Swift LL, Akohoue SA, Shankar SM, Flakoll PJ, Abumrad N. Defects in postabsorptive plasma homeostasis of fatty acids in sickle cell disease. JPEN J Parenter Enteral Nutr. 2007 Jul-Aug; 31(4):263-8.
-
Hofstetter HH, Kovalovsky A, Shive CL, Lehmann PV, Forsthuber TG. Neonatal induction of myelin-specific Th1/Th17 immunity does not result in experimental autoimmune encephalomyelitis and can protect against the disease in adulthood. J Neuroimmunol. 2007 Jul; 187(1-2):20-30.
-
Devan BD, Pistell PJ, Daffin LW, Nelson CM, Duffy KB, Bowker JL, Bharati IS, Sierra-Mercado D, Spangler EL, Ingram DK. Sildenafil citrate attenuates a complex maze impairment induced by intracerebroventricular infusion of the NOS inhibitor Nomega-nitro-L-arginine methyl ester. Eur J Pharmacol. 2007 Jun 01; 563(1-3):134-40.
-
Weiss G, Gordeuk VR. Benefits and risks of iron therapy for chronic anaemias. Eur J Clin Invest. 2005 Dec; 35 Suppl 3:36-45.
-
Nag S, Yee BK, Tang F. Reduction in somatostatin and substance P levels and choline acetyltransferase activity in the cortex and hippocampus of the rat after chronic intracerebroventricular infusion of beta-amyloid (1-40). Brain Res Bull. 1999 Nov 01; 50(4):251-62.
-
Nag S, Yee BK, Tang F. Chronic intracerebroventricular infusion of beta-amyloid (1-40) results in a selective loss of neuropeptides in addition to a reduction in choline acetyltransferase activity in the cortical mantle and hippocampus in the rat. Ann N Y Acad Sci. 1999; 897:420-2.
-
Nashar TO, Stokes CR, Cripps PJ. Immune responses to intramammary infusion with soluble (ovalbumin) and particulate (S uberis) antigens in the preparturient bovine udder. Res Vet Sci. 1991 Mar; 50(2):145-51.